Concepcion F Guillamon
Overview
Explore the profile of Concepcion F Guillamon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pons-Fuster E, Bernal E, Guillamon C, Gimeno L, Martinez-Sanchez M, Ruiz-Lorente I, et al.
Infect Dis (Lond)
. 2024 May;
56(10):818-829.
PMID: 38743055
Background: HIV-1-associated neurocognitive disorders (HAND) in stable patients undergoing antiretroviral therapy (ART) may result from ongoing immune dysregulation and chronic inflammation. A contributing factor may result from the unstable HLA...
2.
Guillamon C, Gimeno L, Server G, Martinez-Sanchez M, Escudero J, Lopez-Cubillana P, et al.
Eur Urol Oncol
. 2019 Aug;
4(2):246-255.
PMID: 31411976
Background: Bladder cancer (BC) is highly immunogenic. Bacillus Calmette-Guérin (BCG) immunotherapy offers the best results in non-muscle-invasive BC (NMIBC). Natural killer cells (NKcs) play decisive roles in BCG-mediated immune response...
3.
Guillamon C, Martinez-Sanchez M, Gimeno L, Campillo J, Server-Pastor G, Martinez-Garcia J, et al.
Cancer Immunol Res
. 2019 Jun;
7(8):1307-1317.
PMID: 31239317
Therapies using NK cells (NKc) expanded/activated or stimulated with new immunostimulatory agents offer alternative opportunities for patients with recurrent/refractory tumors, but relevant biomarkers to guide the selection of patients are...
4.
Bernal E, Martinez M, Torres A, Guillamon C, Alcaraz A, Alcaraz M, et al.
Antiviral Res
. 2018 Dec;
162:163-170.
PMID: 30593833
The main objective of this study is to evaluate the predictive capacity of T cell activation/senescence in subclinical atherosclerosis (SCA) in a group of HIV-infected patients. So, a cross-sectional analysis...
5.
Guillamon C, Martinez-Sanchez M, Gimeno L, Mrowiec A, Martinez-Garcia J, Server-Pastor G, et al.
Cancer Immunol Res
. 2018 Sep;
6(12):1537-1547.
PMID: 30242020
Natural killer cell (NKc)-based therapies offer promising outcomes in patients with tumors, but they could improve with appropriate selection of donors and optimization of methods to expand NKcs Education through...